Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina
- PMID: 29384795
- DOI: 10.1097/MEG.0000000000001079
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort.
Patients and methods: Liver biopsies and serum from 34 NAFLD adult patients were analyzed. Histological parameters were evaluated. Matrix deposition [hyaluronic acid (HA) and tissue inhibitor of matrix metalloproteinase inhibitor-1 (TIMP-1)] and cell-death markers [cytokeratin-18 (M65) and caspase-cleaved cytokeratin-18 (M30)] were measured in serum samples.
Results: HA showed an association with fibrosis severity (P=0.03) and M30 with steatosis (P=0.013), inflammation (P=0.004), and fibrosis severity (P=0.04). In contrast, TIMP-1 and M65 showed no association with any histological parameter of liver injury. The evaluation of diagnostic accuracy showed good performance as less invasive markers of significant fibrosis of both HA (area under the receiver operating characteristic curve: 0.928) and M30 (area under the receiver operating characteristic curve: 0.848).
Conclusion: Biomarkers are essential tools that may provide a quick and accurate diagnosis for patients with life-threatening NAFLD and NASH. HA and M30, together or determined sequentially, have been found to be straightforward tests that may be sufficient to predict significant fibrosis even in a primary care center of an underdeveloped country.
Similar articles
-
Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.Hepatology. 2017 Jul;66(1):96-107. doi: 10.1002/hep.29099. Epub 2017 May 9. Hepatology. 2017. PMID: 28170108
-
Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.Aliment Pharmacol Ther. 2012 Dec;36(11-12):1057-66. doi: 10.1111/apt.12091. Epub 2012 Oct 16. Aliment Pharmacol Ther. 2012. PMID: 23066946
-
Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.Gastroenterol Hepatol. 2017 Jun-Jul;40(6):388-394. doi: 10.1016/j.gastrohep.2017.02.009. Epub 2017 Mar 28. Gastroenterol Hepatol. 2017. PMID: 28359548 English, Spanish.
-
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.Semin Liver Dis. 2015 Aug;35(3):291-303. doi: 10.1055/s-0035-1562948. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378645 Review.
-
Liver fibrosis markers of nonalcoholic steatohepatitis.World J Gastroenterol. 2015 Jun 28;21(24):7427-35. doi: 10.3748/wjg.v21.i24.7427. World J Gastroenterol. 2015. PMID: 26139988 Free PMC article. Review.
Cited by
-
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease.Metabolites. 2023 Oct 29;13(11):1115. doi: 10.3390/metabo13111115. Metabolites. 2023. PMID: 37999211 Free PMC article. Review.
-
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta-Analysis.J Clin Lab Anal. 2025 Apr;39(8):e70034. doi: 10.1002/jcla.70034. Epub 2025 Apr 9. J Clin Lab Anal. 2025. PMID: 40202219 Free PMC article.
-
Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity.Biomolecules. 2023 Apr 14;13(4):675. doi: 10.3390/biom13040675. Biomolecules. 2023. PMID: 37189422 Free PMC article.
-
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.PLoS One. 2020 Sep 11;15(9):e0238717. doi: 10.1371/journal.pone.0238717. eCollection 2020. PLoS One. 2020. PMID: 32915852 Free PMC article.
-
Gd-EOB-DTPA DCE-MRI biomarkers in a rabbit model of liver fibrosis.Am J Transl Res. 2018 Sep 15;10(9):2949-2957. eCollection 2018. Am J Transl Res. 2018. PMID: 30323881 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous